Loading...
Loading...
All product recalls associated with Pdx Aromatics.
Total Recalls
1000
Past Year
303
Class I (Serious)
34
Most Recent
Nov 2025
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
Kraken Kratom, Phytoextractum, and Soul Speciosa RED VEin Kratom Capsule are recalled due to potential contamination with Salmonella.
Kraken Kratom, Phytoextractum, and Soul Speciosa GREEN VEIN Kratom POWDER are recalled due to potential contamination with Salmonella.
Kraken Kratom, Phytoextractum, and Soul Speciosa GREEN VEIN Kratom CAPSULES are recalled due to potential contamination with Salmonella.
Kraken Kratom, Phytoextractum, and Soul Speciosa WHITE VEIN Kratom CAPSULES are recalled due to potential contamination with Salmonella.
Kraken Kratom, Phytoextractum, and Soul Speciosa products containing Red Vein Kratom Powder are recalled due to potential contamination with Salmonella.
Kraken Kratom, Phytoextractum, and Soul Speciosa products containing WHITE VEIN Kratom Powder are recalled due to potential contamination with Salmonella.
Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.
Stability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.
Stability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.
Failed Impurities/Degradation Specifications: High out of specification results for an impurity.
Failed impurities/degradation specifications: Failure to water content and impurity
Failed Impurities/Degradation Specifications: High out of specification results for an impurity.
Failed Impurities/Degradation Specifications: High out of specification results for an impurity.
Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.
Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
Labeling: Label mix-up
Labeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indicates a compounding date of 12/27/2018 and use-by date of 03/27/2019 instead of 12/27/2017 and use-by-date of 03/27/2018
CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.